Previously, we proposed a new classification of tumor microvessels (MVs) on the basis of their morphological features and clinical significance. The aim of this study was to summarize the obtained results and establish the predictive value of different types of tumor MVs for assessing the risk of metastasis to regional lymph nodes (RLNs) in glandular and squamous cell carcinomas. Materials and methods. A total of 385 archival samples of gastric cancer stages I--III, breast cancer stages I--IIIA, cervical squamous cell carcinoma stages I--IIA, and lung squamous cell carcinoma stages I--IIIA were studied. The tumor sections were processed routinely and subjected to immunohistochemistry with antibodies against cluster of differentiation 34 (CD34) and podoplanin. To assess independent predictors of the risk of metastasis to RLNs, correlation analysis and univariate and multivariate logistic regression analyses were performed. Statistical analysis was performed via Statistica 10.0 software. Results. For patients with gastric cancer and breast cancer, the independent predictors of a high risk of metastasis to RLNs are T2 (p=0.007) and T3 (p<0.00001) stages, tumor grade 3 (p=0.0002), the presence of lymphovascular invasion (LVI) (p=0.044) and peritumoral retraction clefts (p=0.008). For patients with squamous cell carcinoma of the cervix and lung, independent predictors of a high risk of metastasis to RLNs are the T2 (p=0.01) and T3 (p=0.007) stages, the presence of LVI (p=0.0014), dilated capillaries (DCs) of the "contact type" (p=0.0007), capillaries in the tumor solid component (p=0.046) and peritumoral retraction cleftings (p=0.0006). Conclusion. The results of the present study indicate that when assessing the risk of metastasis to RLNs, it is advisable to consider the presence of peritumoral retraction clefting and LVI in both glandular and squamous cell carcinomas. In addition, in squamous cell carcinomas, the accuracy of assessing the risk of metastasis to RLNs can be increased by taking into account "contact-type" DCs and capillaries in the solid component of the tumor.
| Published in | American Journal of Clinical and Experimental Medicine (Volume 12, Issue 5) |
| DOI | 10.11648/j.ajcem.20241205.11 |
| Page(s) | 61-73 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Gastric Cancer, Breast Cancer, Cervical Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Tumor Microvessels, Regional Metastases
| [1] | Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971 Nov 18; 285(21): 1182-6. |
| [2] | Folkman J. Tumor angiogenesis and tissue factor. Nat Med. 1996 Feb; 2(2): 167-8. |
| [3] | Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002 Dec; 29(6 Suppl 16): 15-8. |
| [4] | Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med. 2019 Dec 29; 9(1): 84. |
| [5] | Schito L. Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer. Adv Exp Med Biol. 2019; 136: 71-85. |
| [6] | Guo M, Niu Y, Xie M, Liu X, Li X. Notch signaling, hypoxia, and cancer. Front Oncol. 2023 Jan 31; 13: 1078768. |
| [7] | Al-Ostoot FH, Salah S, Khamees HA, Khanum SA (2021) Tumor angiogenesis: Current challenges and therapeutic opportunities. Cancer Treat Res Commun 28: 100422. |
| [8] | Dudley AC, Griffioen AW (2023) Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis 26(3): 313-347. |
| [9] | Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3): 739-52. |
| [10] | Sun B, Zhang D, Zhao N, Zhao X (2017) Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Oncotarget 8(18): 30502-30510. |
| [11] | Barnett FH, Rosenfeld M, Wood M, Kiosses WB, Usui Y, Marchetti V, Aguilar E, Friedlander M (2016) Macrophages form functional vascular mimicry channels in vivo. Sci Rep 6: 36659. |
| [12] | Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-7. |
| [13] | Fisher DT, Muhitch JB, Kim M, Doyen KC, Bogner PN, Evans SS, Skitzki JJ (2016) Intraoperative intravital microscopy permits the study of human tumour vessels. Nat Commun 7: 10684. |
| [14] | Yu M, Men HT, Niu ZM, Zhu YX, Tan BX, Li LH, Jiang J (2015) Meta-Analysis of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells as Prognostic Factors in Lung Cancer. Asian Pac J Cancer Prev 16(14): 6123-8. |
| [15] | Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8(1): 198. |
| [16] | Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR (2019) Vessel co-option in cancer. Nat Rev Clin Oncol 16(8): 469-493. |
| [17] | Burri PH, Hlushchuk R, Djonov V (2004) Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 231(3): 474-88. |
| [18] | Ribatti D, Djonov V (2012) Intussusceptive microvascular growth in tumors. Cancer Lett 316(2): 126-31. |
| [19] | Ribatti D, Tamma R, Annese T, d'Amati A, Ingravallo G, Specchia G (2023) Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways. Cancers (Basel) 15(12): 3262. |
| [20] | Klein D (2018) The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy. Front Oncol 8: 367. |
| [21] | Nagy JA, Dvorak HF (2012) Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets. Clin Exp Metastasis 29(7): 657-62. |
| [22] | Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156(4): 1363-80. |
| [23] | Birau A, Ceausu RA, Cimpean AM, Gaje P, Raica M, Olariu T (2012) Assessement of angiogenesis reveals blood vessel heterogeneity in lung carcinoma. Oncol Lett 4(6): 1183-1186. |
| [24] | Milosevic V, Edelmann RJ, Winge I, Strell C, Mezheyeuski A, Knutsvik G, Askeland C, Wik E, Akslen LA, Östman A (2023) Vessel size as a marker of survival in estrogen receptor positive breast cancer. Breast Cancer Res Treat 200(2): 293-304. |
| [25] | Rofstad EK, Galappathi K, Mathiesen BS (2014) Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia 16(7): 586-94. |
| [26] | Tomita T, Kato M, Hiratsuka S (2021) Regulation of vascular permeability in cancer metastasis. Cancer Sci 112(8): 2966-2974. |
| [27] | Pezzella F, Gatter K, Qian CN (2016) Twenty years after: the beautiful hypothesis and the ugly facts. Chin J Cancer 35: 22. |
| [28] | Pezzella F, Ribatti D (2022) Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies. Cancer Rep (Hoboken) 5(12): e1318. |
| [29] | Petrovic N (2016) Targeting Angiogenesis in Cancer Treatments: Where do we Stand? J Pharm Pharm Sci 19(2): 226-38. |
| [30] | Sitohy B, Chang S, Sciuto TE, Masse E, Shen M, Kang PM, Jaminet SC, Benjamin LE, Bhatt RS, Dvorak AM, Nagy JA, Dvorak HF (2017) Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels. Am J Pathol 187(10): 2337-2347. |
| [31] | Ribatti D, Pezzella F (2021) Overview on the Different Patterns of Tumor Vascularization. Cells 10(3): 639. |
| [32] | Sitohy B, Nagy JA, Jaminet SC, Dvorak HF (2011) Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy. Cancer Res 71(22): 7021-8. |
| [33] | Raica M, Cimpean AM, Ferician OC, Ferician AM (2021) Tumour-associated Angiogenesis and Intermediate Blood Vessels in Renal Cell Carcinoma. Cancer Diagn Progn 1(3): 231-234. |
| [34] | Senchukova M, Kiselevsky MV (2014) The "cavitary" type of angiogenesis by gastric cancer. Morphological characteristics and prognostic value. J Cancer 5(5): 311-9. |
| [35] | Senchukova MA, Nikitenko NV, Tomchuk ON, Zaitsev NV, Stadnikov AA (2015) Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus 4: 512. |
| [36] | Senchukova MA, Makarova EV, Shurygina EI, Volchenko NN (2020) Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer. J Oncol 2020: 3818051. |
| [37] | Senchukova MA, Kalinin EA, Volchenko NN. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance. World J Clin Oncol. 2024 May 24; 15(5): 614-634. |
| [38] | Senchukova, M. A. (2024). Morphological Features and Clinical Significance of Tumor Microvessels in Glandular and Squamous Cell Cancers. In: Interdisciplinary Cancer Research. Springer, Cham. |
| [39] | Jeong O, Jung MR, Kang JH. Prognostic Value of the Anatomic Region of Metastatic Lymph Nodes in the Current TNM Staging of Gastric Cancer. J Gastric Cancer. 2021 Sep, 21(3): 236-245. |
| [40] | Purich K, Skubleny D, Ghosh S, Bédard ELR, Stewart KC, Johnson ST, Haase E, McCall M, Schiller D. A prospective Canadian gastroesophageal cancer database: What have we learned? Can J Surg. 2023 Aug 8; 66(4): E422-E431. |
| [41] | Cetin IA, Akay SU, Caglar Ozkok HB, Sengoz M. Lymph node ratio as an independent prognostic factor for breast cancer-related mortality in patients with node-positive breast cancer. J Cancer Res Ther. 2020 Oct-Dec; 16(6): 1387-1392. |
| [42] | Zarean Shahraki S, Azizmohammad Looha M, Mohammadi Kazaj P, Aria M, Akbari A, Emami H, Asadi F, Akbari ME. Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models. Front Oncol. 2023 Jun 5; 13: 1147604. |
| [43] | Wang M, Ma M, Yang L, Liang C. Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer. Front Oncol. 2022 Sep 2; 12: 952347. |
| [44] | Kwon J, Eom KY, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Res Treat. 2018 Jul; 50(3): 964-974. |
| [45] | Guo D, Ni Y, Lv X, Zhang Z, Ye P. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer. J Cancer Res Ther. 2016 Oct; 12(Supplement): 120-125. |
| [46] | Łochowski MP, Chałubińska-Fendler J, Szlachcińska A, Łochowska B, Brzeziński D, Kaczmarski J, Kozak J. Prognostic Value of Lymph Node Ratio (LNR) in Patients with Postoperative N2 Feature in Non-Small Cell Lung Cancer (NSCLC). J Clin Med. 2024 Aug 5; 13(15): 4570. |
| [47] | Goyal AV, Shukla S, Acharya S, Vagha S, Jajoo S. Correlation of microvessel density with histopathological parameters of carcinoma breast. Indian J Med Res. 2023 Oct 1; 158(4): 417-422. |
| [48] | Wu Y, Chen D, Luo Y, Wang J, Gong H, Li J, Jiang L. Expression and clinical significance of SYNE3 in non-small cell lung cancer. Am J Transl Res. 2024 Sep 15; 16(9): 4436-4449. |
| [49] | Zhang Y, Qu H. Expression and clinical significance of aquaporin-1, vascular endothelial growth factor and microvessel density in gastric cancer. Medicine (Baltimore). 2020 Sep 4; 99(36): e21883. |
| [50] | Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018 Oct 3; 18: 152. |
| [51] | Zhao K, Zhao T, Yang R, Liu J, Hu M. Peroxiredoxin 2 as a potential prognostic biomarker associated with angiogenesis in cervical squamous cell cancer. Oncol Lett. 2024 May 16; 28(1): 328. |
| [52] | Zhang T, Nie J, Liu X, Han Z, Ding N, Gai K, Liu Y, Chen L, Guo C. Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer. Clin Transl Sci. 2021 Jan; 14(1): 389-394. |
| [53] | Abbasi A, Ghaffarizadeh F, Mojdeganlou H. Prognostic Significance of Microvessel Density in Invasive Ductal Carcinoma of Breast. Int J Hematol Oncol Stem Cell Res. 2023 Apr 1; 17(2): 100-105. |
| [54] | Kubik S, Jesionek-Kupnicka D, Stawiski K, Fijuth J, Moszynska-Zielinska M, Kuncman L, Pajdzinski M, Gottwald L. Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma. J Obstet Gynaecol. 2022 Aug; 42(6): 2248-2254. |
| [55] | Lai TY, Chiang TC, Lee CY, Kuo TC, Wu CH, Chen YI, Hu CM, Maskey M, Tang SC, Jeng YM, Tien YW, Lee EYP, Lee WH. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Br J Cancer. 2024 Apr; 130(7): 1096-1108. |
| [56] | Wang B, Han Y, Liu J, Zhang X, Deng Y, Jiang Y. Intratumoral high endothelial venules in solid tumors: a pooled study. Front Immunol. 2024 Jul 8; 15: 1401118. |
| [57] | Mamilos A, Lein A, Winter L, Haas M, Reichert TE, Ettl T, Künzel J, Spanier G, Brochhausen C. Immunohistochemical Assessment of Microvessel Density in OSCC: Spatial Heterogeneity of Angiogenesis and Its Impact on Survival. Biomedicines. 2023 Oct 8; 11(10): 2724. |
| [58] | Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol. 2009 Mar; 112(3): 583-9. |
| [59] | Tong YH, He Y, Hu LY, Liu YJ, Zheng XW, Sun J, Song Y, Zhang YW, Fang L, Huang P. Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer. Tumori. 2019 Dec; 105(6): 494-500. |
| [60] | Ding H, Sun J, Song Y, Xin W, Zhu J, Zhong L, Chen Y, Zhang Y, Tong Y, Fang L. Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients. Front Oncol. 2021 Jun 11; 11: 632352. |
| [61] | Ferician AM, Ferician OC, Nesiu A, Cosma AA, Caplar BD, Melnic E, Cimpean AM. The Mutually Mediated Chloride Intracellular Channel Protein 1 (CLIC1) Relationship between Malignant Cells and Tumor Blood Vessel Endothelium Exhibits a Significant Impact on Tumor Angiogenesis, Progression, and Metastasis in Clear Cell Renal Cell Carcinoma (ccRCC). Cancers (Basel). 2022 Dec 3; 14(23): 5981. |
| [62] | Zhang X, Ji J, Zhang G, Fang C, Jiang F, Ma S, Hou J. Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma. Onco Targets Ther. 2017 Nov 13; 10: 5417-5424. |
| [63] | Lu M, Tian H, Yue W, Li L, Li S, Qi L, Hu W, Gao C, Si L. TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis. PLoS One. 2014 Feb 11; 9(2): e88032. |
| [64] | Acs G, Dumoff KL, Solin LJ, Pasha T, Xu X, Zhang PJ. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Am J Surg Pathol. 2007 Jan; 31(1): 129-40. |
| [65] | Huang L, Li Y, Du J, Li H, Lu M, Wang Y, Zhou W, Wang W, Wu H. The Prognostic Value of Retraction Clefts in Chinese Invasive Breast Cancer Patients. Pathol Oncol Res. 2021 Apr 21; 27: 1609743. |
| [66] | Acs G, Khakpour N, Kiluk J, Lee MC, Laronga C. The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol. 2015 Mar; 39(3): 325-37. |
| [67] | Li W, Jia H, Wang S, Guo X, Zhang X, Zhang L, Wen HY, Fu L. The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients. Ann Diagn Pathol. 2022 Dec; 61: 152047. |
APA Style
Senchukova, M. (2024). New Classification of Tumor Microvessels and the Risk of Regional Metastasis in Squamous Cell and Glandular Cancers. American Journal of Clinical and Experimental Medicine, 12(5), 61-73. https://doi.org/10.11648/j.ajcem.20241205.11
ACS Style
Senchukova, M. New Classification of Tumor Microvessels and the Risk of Regional Metastasis in Squamous Cell and Glandular Cancers. Am. J. Clin. Exp. Med. 2024, 12(5), 61-73. doi: 10.11648/j.ajcem.20241205.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajcem.20241205.11,
author = {Marina Senchukova},
title = {New Classification of Tumor Microvessels and the Risk of Regional Metastasis in Squamous Cell and Glandular Cancers
},
journal = {American Journal of Clinical and Experimental Medicine},
volume = {12},
number = {5},
pages = {61-73},
doi = {10.11648/j.ajcem.20241205.11},
url = {https://doi.org/10.11648/j.ajcem.20241205.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20241205.11},
abstract = {Previously, we proposed a new classification of tumor microvessels (MVs) on the basis of their morphological features and clinical significance. The aim of this study was to summarize the obtained results and establish the predictive value of different types of tumor MVs for assessing the risk of metastasis to regional lymph nodes (RLNs) in glandular and squamous cell carcinomas. Materials and methods. A total of 385 archival samples of gastric cancer stages I--III, breast cancer stages I--IIIA, cervical squamous cell carcinoma stages I--IIA, and lung squamous cell carcinoma stages I--IIIA were studied. The tumor sections were processed routinely and subjected to immunohistochemistry with antibodies against cluster of differentiation 34 (CD34) and podoplanin. To assess independent predictors of the risk of metastasis to RLNs, correlation analysis and univariate and multivariate logistic regression analyses were performed. Statistical analysis was performed via Statistica 10.0 software. Results. For patients with gastric cancer and breast cancer, the independent predictors of a high risk of metastasis to RLNs are T2 (p=0.007) and T3 (pConclusion. The results of the present study indicate that when assessing the risk of metastasis to RLNs, it is advisable to consider the presence of peritumoral retraction clefting and LVI in both glandular and squamous cell carcinomas. In addition, in squamous cell carcinomas, the accuracy of assessing the risk of metastasis to RLNs can be increased by taking into account "contact-type" DCs and capillaries in the solid component of the tumor.
},
year = {2024}
}
TY - JOUR T1 - New Classification of Tumor Microvessels and the Risk of Regional Metastasis in Squamous Cell and Glandular Cancers AU - Marina Senchukova Y1 - 2024/11/29 PY - 2024 N1 - https://doi.org/10.11648/j.ajcem.20241205.11 DO - 10.11648/j.ajcem.20241205.11 T2 - American Journal of Clinical and Experimental Medicine JF - American Journal of Clinical and Experimental Medicine JO - American Journal of Clinical and Experimental Medicine SP - 61 EP - 73 PB - Science Publishing Group SN - 2330-8133 UR - https://doi.org/10.11648/j.ajcem.20241205.11 AB - Previously, we proposed a new classification of tumor microvessels (MVs) on the basis of their morphological features and clinical significance. The aim of this study was to summarize the obtained results and establish the predictive value of different types of tumor MVs for assessing the risk of metastasis to regional lymph nodes (RLNs) in glandular and squamous cell carcinomas. Materials and methods. A total of 385 archival samples of gastric cancer stages I--III, breast cancer stages I--IIIA, cervical squamous cell carcinoma stages I--IIA, and lung squamous cell carcinoma stages I--IIIA were studied. The tumor sections were processed routinely and subjected to immunohistochemistry with antibodies against cluster of differentiation 34 (CD34) and podoplanin. To assess independent predictors of the risk of metastasis to RLNs, correlation analysis and univariate and multivariate logistic regression analyses were performed. Statistical analysis was performed via Statistica 10.0 software. Results. For patients with gastric cancer and breast cancer, the independent predictors of a high risk of metastasis to RLNs are T2 (p=0.007) and T3 (pConclusion. The results of the present study indicate that when assessing the risk of metastasis to RLNs, it is advisable to consider the presence of peritumoral retraction clefting and LVI in both glandular and squamous cell carcinomas. In addition, in squamous cell carcinomas, the accuracy of assessing the risk of metastasis to RLNs can be increased by taking into account "contact-type" DCs and capillaries in the solid component of the tumor. VL - 12 IS - 5 ER -
Department of Oncology, Orenburg State Medical University, Orenburg, Russia
